Back
Pan American Silver Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
84
PAAS
Pan American Silver Corp.
Last Price:
$50.04
Seasonality Move:
8.63%
Sell
34
MNPR
Monopar Therapeutics, Inc.
Last Price:
$65.70
Seasonality Move:
25.93%
Buy
84
Pan American Silver Corp. (PAAS)
is a Buy
Is Pan American Silver Corp. a Buy, Sell or Hold?
-
The current Pan American Silver Corp. [PAAS] share price is $50.00. The Score for PAAS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
PAAS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAAS Stock Price Chart
What is Pan American Silver Corp.'s stock price today?
-
The Pan American Silver Corp. share price today is $50.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAAS is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $67.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
PAAS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.1 | Buy |
| Relative Strength Index (14 RSI): | 71.6 | Buy |
| Chaikin Money Flow: | 794247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.66 - 48.04) | Buy |
| Bollinger Bands (100): | (31.81 - 42.35) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.86 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -124010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (74.34 - 86.38) | Sell |
| Bollinger Bands (100): | (44.81 - 88.99) | Buy |
PAAS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.66 | Buy |
| 20-day SMA: | 44.61 | Buy |
| 50-day SMA: | 40.13 | Buy |
| 200-day SMA: | 31.76 | Buy |
| 8-day EMA: | 48.5 | Buy |
| 20-day EMA: | 45.4 | Buy |
| 50-day EMA: | 41.37 | Buy |
| 200-day EMA: | 33.39 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Sell |
| 20-day SMA: | 80.22 | Sell |
| 50-day SMA: | 82.77 | Sell |
| 200-day SMA: | 51.96 | Buy |
| 8-day EMA: | 74.03 | Sell |
| 20-day EMA: | 77.79 | Sell |
| 50-day EMA: | 77.58 | Sell |
| 200-day EMA: | 56.47 | Buy |
Pan American Silver Corp. Earnings Growth & PAAS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.58 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Pan American Silver Corp. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||